These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 31171269)

  • 21. Ursolic acid improves diabetic nephropathy via suppression of oxidative stress and inflammation in streptozotocin-induced rats.
    Xu HL; Wang XT; Cheng Y; Zhao JG; Zhou YJ; Yang JJ; Qi MY
    Biomed Pharmacother; 2018 Sep; 105():915-921. PubMed ID: 30021385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ganoderma lucidum ameliorates the diabetic nephropathy via down-regulatory effect on TGFβ-1 and TLR-4/NFκB signalling pathways.
    Hassan HM; Mahran YF; Ghanim AMH
    J Pharm Pharmacol; 2021 Aug; 73(9):1250-1261. PubMed ID: 33847358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of diabetic nephropathy by Chaihuang-Yishen granule through anti-inflammatory mechanism in streptozotocin-induced rat model of diabetics.
    Zhang H; Zhao T; Gong Y; Dong X; Zhang W; Sun S; Wang H; Gu Y; Lu X; Yan M; Li P
    J Ethnopharmacol; 2014; 151(1):556-64. PubMed ID: 24269779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of iRhom-2/Tumor Necrosis Factor-α Converting Enzyme Pathway and Oxidative Stress Protects the Renal Injury with Anemonin in Streptozotocin-Induced Diabetic Nephropathy Neonatal Rat Model.
    Qiao L; Liu Y; Li C; Ge J; Li T
    Pharmacology; 2019; 104(5-6):258-266. PubMed ID: 31344701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Timosaponin B-II ameliorates diabetic nephropathy via TXNIP, mTOR, and NF-κB signaling pathways in alloxan-induced mice.
    Yuan YL; Guo CR; Cui LL; Ruan SX; Zhang CF; Ji D; Yang ZL; Li F
    Drug Des Devel Ther; 2015; 9():6247-58. PubMed ID: 26664046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Notoginsenoside R1 ameliorates podocyte injury in rats with diabetic nephropathy by activating the PI3K/Akt signaling pathway.
    Huang G; Lv J; Li T; Huai G; Li X; Xiang S; Wang L; Qin Z; Pang J; Zou B; Wang Y
    Int J Mol Med; 2016 Oct; 38(4):1179-89. PubMed ID: 27571993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amygdalin alleviates renal injury by suppressing inflammation, oxidative stress and fibrosis in streptozotocin-induced diabetic rats.
    Chen J; Hu Y; Mou X; Wang H; Xie Z
    Life Sci; 2021 Jan; 265():118835. PubMed ID: 33253723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase.
    Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Geniposide reduces development of streptozotocin-induced diabetic nephropathy via regulating nuclear factor-kappa B signaling pathways.
    Hu X; Zhang X; Jin G; Shi Z; Sun W; Chen F
    Fundam Clin Pharmacol; 2017 Feb; 31(1):54-63. PubMed ID: 27521287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein C3 aggravates diabetic nephropathy in type 1 diabetes by activating the renal TLR2/NF-κB pathway.
    Wang H; Huang X; Xu P; Liu X; Zhou Z; Wang F; Li J; Wang Y; Xian X; Liu G; Huang W
    Metabolism; 2021 Jun; 119():154740. PubMed ID: 33639183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing PEG3 inhibits renal fibrosis in a rat model of diabetic nephropathy by suppressing the NF-κB pathway.
    Guan T; Fang F; Su X; Lin K; Gao Q
    Mol Cell Endocrinol; 2020 Aug; 513():110823. PubMed ID: 32311421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and optimization of crocetin loaded PLGA nanoparticles against diabetic nephropathy via suppression of inflammatory biomarkers: a formulation approach to preclinical study.
    Yang X
    Drug Deliv; 2019 Dec; 26(1):849-859. PubMed ID: 31524015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study on the inhibitive effect of Catalpol on diabetic nephropathy.
    Chen J; Yang Y; Lv Z; Shu A; Du Q; Wang W; Chen Y; Xu H
    Life Sci; 2020 Sep; 257():118120. PubMed ID: 32693244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calycosin Ameliorates Diabetes-Induced Renal Inflammation via the NF-κB Pathway In Vitro and In Vivo.
    Zhang YY; Tan RZ; Zhang XQ; Yu Y; Yu C
    Med Sci Monit; 2019 Mar; 25():1671-1678. PubMed ID: 30830898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
    Liu P; Li F; Qiu M; He L
    Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Danzhi Jiangtang Capsule ameliorates kidney injury via inhibition of the JAK-STAT signaling pathway and increased antioxidant capacity in STZ-induced diabetic nephropathy rats.
    Sun M; Bu W; Li Y; Zhu J; Zhao J; Zhang P; Gu L; Zhang W; Fang Z
    Biosci Trends; 2019 Jan; 12(6):595-604. PubMed ID: 30606979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
    Song W; Wei L; Du Y; Wang Y; Jiang S
    Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow mesenchymal stem cells ameliorated kidney fibrosis by attenuating TLR4/NF-κB in diabetic rats.
    Lin L; Lin H; Wang D; Bao Z; Cai H; Zhang X
    Life Sci; 2020 Dec; 262():118385. PubMed ID: 32926926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Danshen injection ameliorates STZ-induced diabetic nephropathy in association with suppression of oxidative stress, pro-inflammatory factors and fibrosis.
    Xu L; Shen P; Bi Y; Chen J; Xiao Z; Zhang X; Wang Z
    Int Immunopharmacol; 2016 Sep; 38():385-94. PubMed ID: 27355131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Mobility Group Box1 Inhibitor Glycyrrhizic Acid Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats.
    Zhang H; Zhang R; Chen J; Shi M; Li W; Zhang X
    Kidney Blood Press Res; 2017; 42(5):894-904. PubMed ID: 29241180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.